Cargando…

Wnt5A Signaling Blocks Progression of Experimental Visceral Leishmaniasis

Visceral leishmaniasis, caused by L. donovani infection is fatal if left untreated. The intrinsic complexity of visceral leishmaniasis complicated further by the increasing emergence of drug resistant L. donovani strains warrants fresh investigations into host defense schemes that counter infections...

Descripción completa

Detalles Bibliográficos
Autores principales:	Maity, Shreyasi, Chakraborty, Arijit, Mahata, Sushil Kumar, Roy, Syamal, Das, Anjan Kumar, Sen, Malini
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8859155/ https://www.ncbi.nlm.nih.gov/pubmed/35197983 http://dx.doi.org/10.3389/fimmu.2022.818266

Ejemplares similares

Wnt5A Signaling Promotes Defense Against Bacterial Pathogens by Activating a Host Autophagy Circuit
por: Jati, Suborno, et al.
Publicado: (2018)

Immunobiology of visceral leishmaniasis
por: Kumar, Rajiv, et al.
Publicado: (2012)

T Lymphocyte Exhaustion During Human and Experimental Visceral Leishmaniasis
por: Costa-Madeira, Juliana C., et al.
Publicado: (2022)

Phenotypical Characterization of Spleen Remodeling in Murine Experimental Visceral Leishmaniasis
por: de Melo, Caroline Vilas Boas, et al.
Publicado: (2020)

Visceral Leishmaniasis: Advancements in Vaccine Development via Classical and Molecular Approaches
por: Joshi, Sumit, et al.
Publicado: (2014)

Wnt5A Signaling Regulates Gut Bacterial Survival and T Cell Homeostasis
por: Sengupta, Soham, et al.
Publicado: (2022)

Genetically Modified Organisms and Visceral Leishmaniasis
por: Chhajer, Rudra, et al.
Publicado: (2014)

Use of Antimony in the Treatment of Leishmaniasis: Current Status and Future Directions
por: Haldar, Arun Kumar, et al.
Publicado: (2011)

Resistance to Experimental Visceral Leishmaniasis in Mice Infected With Leishmania infantum Requires Batf3
por: Soto, Manuel, et al.
Publicado: (2020)

Immunotherapy and Immunochemotherapy in Visceral Leishmaniasis: Promising Treatments for this Neglected Disease
por: Roatt, Bruno Mendes, et al.
Publicado: (2014)

Short-Course Treatment With Imipramine Entrapped in Squalene Liposomes Results in Sterile Cure of Experimental Visceral Leishmaniasis Induced by Antimony Resistant Leishmania donovani With Increased Efficacy
por: Mukherjee, Sandip, et al.
Publicado: (2020)

Galectin-1 Impairs the Generation of Anti-Parasitic Th1 Cell Responses in the Liver during Experimental Visceral Leishmaniasis
por: Bunn, Patrick T., et al.
Publicado: (2017)

The role of mucosal-associated invariant T cells in visceral leishmaniasis
por: Moreira, Marcela de Lima, et al.
Publicado: (2022)

Differential Regulation of miRNA Profiles of Human Cells Experimentally Infected by Leishmania donovani Isolated From Indian Visceral Leishmaniasis and Post-Kala-Azar Dermal Leishmaniasis
por: Kumar, Ashish, et al.
Publicado: (2020)

Transcriptome Analysis Identifies Immune Markers Related to Visceral Leishmaniasis Establishment in the Experimental Model of BALB/c Mice
por: Agallou, Maria, et al.
Publicado: (2019)

Live Vaccination Tactics: Possible Approaches for Controlling Visceral Leishmaniasis
por: Saljoughian, Noushin, et al.
Publicado: (2014)

The Contribution of Immune Evasive Mechanisms to Parasite Persistence in Visceral Leishmaniasis
por: de Freitas, Elisangela Oliveira, et al.
Publicado: (2016)

Determinants of Innate Immunity in Visceral Leishmaniasis and Their Implication in Vaccine Development
por: Volpedo, Greta, et al.
Publicado: (2021)

Therapeutic Potential of Photosynthetic Microorganisms for Visceral Leishmaniasis: An Immunological Analysis
por: Vaitkevicius-Antão, Victor, et al.
Publicado: (2022)

Cytokines: Key Determinants of Resistance or Disease Progression in Visceral Leishmaniasis: Opportunities for Novel Diagnostics and Immunotherapy
por: Dayakar, Alti, et al.
Publicado: (2019)

Therapy with radio-attenuated vaccine in experimental murine visceral leishmaniasis showed enhanced T cell and inducible nitric oxide synthase levels, suppressed tumor growth factor-beta production with higher expression of some signaling molecules
por: Datta, Sanchita, et al.
Publicado: (2014)

Wnt Signaling: Pathogen Incursion and Immune Defense
por: Jati, Suborno, et al.
Publicado: (2019)

Immunomodulatory Therapy of Visceral Leishmaniasis in Human Immunodeficiency Virus-Coinfected Patients
por: Adriaensen, Wim, et al.
Publicado: (2018)

Wnt5A signaling supports antigen processing and CD8 T cell activation
por: Sarraf, Tresa Rani, et al.
Publicado: (2022)

Identification of Potential MHC Class-II-Restricted Epitopes Derived from Leishmania donovani Antigens by Reverse Vaccinology and Evaluation of Their CD4+ T-Cell Responsiveness against Visceral Leishmaniasis
por: Dikhit, Manas Ranjan, et al.
Publicado: (2017)

Regulation of PKC Mediated Signaling by Calcium during Visceral Leishmaniasis
por: Roy, Nivedita, et al.
Publicado: (2014)

Pharmacotherapeutic Options for Visceral Leishmaniasis—Current Scenario
por: Pandey, Krishna, et al.
Publicado: (2009)

Biomarkers of Safety and Immune Protection for Genetically Modified Live Attenuated Leishmania Vaccines Against Visceral Leishmaniasis – Discovery and Implications
por: Gannavaram, Sreenivas, et al.
Publicado: (2014)

Immunotherapy and Targeted Therapies in Treatment of Visceral Leishmaniasis: Current Status and Future Prospects
por: Singh, Om Prakash, et al.
Publicado: (2014)

Detection of Leptomonas seymouri narna-like virus in serum samples of visceral leishmaniasis patients and its possible role in disease pathogenesis
por: Sukla, Soumi, et al.
Publicado: (2022)

Wnt5A-Mediated Actin Organization Regulates Host Response to Bacterial Pathogens and Non-Pathogens
por: Jati, Suborno, et al.
Publicado: (2021)

The dynamics of granuloma formation in experimental visceral leishmaniasis
Publicado: (1988)

Visceral leishmaniasis: Experimental models for drug discovery
por: Gupta, Suman, et al.
Publicado: (2011)

Hemophagocytosis in Experimental Visceral Leishmaniasis by Leishmania donovani
por: Morimoto, Ayako, et al.
Publicado: (2016)

Role of Cytokines in Experimental and Human Visceral Leishmaniasis
por: Samant, Mukesh, et al.
Publicado: (2021)

TLR4 and TLR9 polymorphism: Probable role in susceptibility among the population of Bihar for Indian visceral leishmaniasis
por: Mandal, Abhishek, et al.
Publicado: (2021)

Evolutionary genomics of epidemic visceral leishmaniasis in the Indian subcontinent
por: Imamura, Hideo, et al.
Publicado: (2016)

In vivo experiments demonstrate the potent antileishmanial efficacy of repurposed suramin in visceral leishmaniasis
por: Khanra, Supriya, et al.
Publicado: (2020)

Prophylactic interferon-γ and interleukin-17 facilitate parasite clearance in experimental visceral leishmaniasis
por: Kumar, Prabin, et al.
Publicado: (2019)

Visceral leishmaniasis
por: Sundar, Shyam
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_681p1ve4er4re3ohkfo91f8qp8